Academic Handbook Course Descriptors and Programme Specifications
LBIOL4276A Regulatory Environment In Clinical Trials Course Descriptor
Course Code | LBIOL4276A | Discipline | Bioscience and Chemistry |
UK Credit | 30 | US Credit | N/A |
FHEQ level | 4 | Date approved | July 2024 |
Pre-requisites | None | ||
Co-requisites | None | ||
Required/Optional | Required |
Course Overview
This course is an eight-week course that includes an intensive two-week block of face-to-face teaching and project work that helps learners to delve into the regulatory landscape of clinical research. In particular, learners examine the purpose of Good Clinical Practice (GCP). The course covers the basic principles of GCP, the International Conference on Harmonisation (ICH) GCP guidelines, the responsibilities of key stakeholders such as sponsors, investigators and ethics committees. It also explores the role of regulatory authorities and how these are set-up across various regions (inside and outside the ICH area). The varied roles within clinical trials, and how the skills developed in the workplace support the upholding of GCP and the safety and well being of participants at large, is also discussed. Finally, the course also explores methods of communication and the impact they have on professional practice.
Learning Outcomes
On successful completion of the course, learners will be able to:
Knowledge and Understanding
K1a | Analyse the basic principles of Good Clinical Practice (GCP) and its design to protect the rights, safety and wellbeing of clinical research subjects.
|
K2a
K3a |
Explain who the regulatory authorities are for clinical research and be able to compare and contrast these within regions.
Define the legislation that governs clinical trials and the role of regulatory authorities in activities such as marketing authorisations, clinical trial applications, and regulatory inspections. |
Subject Specific Skills
S1a | Evaluate the complexities of regulation through case studies. |
S2a | Analyse the challenges of implementing Good Clinical Practice, including in the workplace. |
S3a | Identify and analyse the pertinent regulations and stakeholders involved in order to maintain Good Clinical Practice. |
Transferable and Professional Skills
T1a | Take personal responsibility in professional development and learning. |
T2a | Apply problem-solving skills to develop solutions to problems. |
T3ai | Communicate analysis clearly and logically. |
T3aii | Display a developing technical proficiency in written English and an ability to communicate clearly and accurately in structured and coherent pieces of writing. |
Teaching and Learning
This is an e-learning course, taught throughout the year.
This course can be offered as a standalone short course.
Teaching and learning strategies for this course will include:
- Online learning
- Online discussion groups
- Online assessment
Course information and supplementary materials will be available on the University’s Virtual Learning Environment (VLE).
Learners are required to attend and participate in all the formal and timetabled sessions for this course. Learners are also expected to manage their self-directed learning and independent study in support of the course.
The course learning and teaching hours will be structured as follows:
- Off-the-job learning and teaching (16 days x 7 hours) = 112 hours
- On-the-job learning (24 days x 7 hours) = 168 hours
- Private study = 20 hours
Total = 300 hours
Workplace assignments (see below) will be completed as part of on-the-job learning.
Assessment
Formative
Learners will be formatively assessed during the course by means of set assignments. These will not count towards the final degree but will provide students with developmental feedback.
Summative
AE | Assessment Type | Weighting | Duration | Length |
1 | Presentation | 30% | 10 minutes | |
2 | Portfolio | 70% | Requiring on average 20 – 30 hours to complete |
Feedback
Learners will receive formal feedback in a variety of ways: written (via email or VLE correspondence) and indirectly through online discussion groups. Learners will also attend a formal meeting with their Academic Advisor or Success Manager (and for apprentices, including their Line Manager). These bi or tri-partite reviews will monitor and evaluate the learner’s progress.
Feedback is provided on summatively assessed assignments and through generic internal examiners’ reports, both of which are posted on the VLE.
Indicative Reading
Note: Comprehensive and current reading lists for courses are produced annually in the Course Syllabus or other documentation provided to learners; the indicative reading list provided below is used as part of the approval/modification process only.
Books
Kritikos, M. (2018). Governing Gene Editing in the European Union: Legal and Ethical Considerations. In Ethics and Integrity in Health and Life Sciences Research (Vol. 4, pp. 99–114). Emerald Publishing Limited.
Smyth, R. L. (2011). Regulation and governance of clinical research in the UK. BMJ (Online), 342, d238-.
Journals
Learners are encouraged to read material from relevant journals on chemistry for the life sciences as directed by their course leader.
Electronic Resources
Learners are encouraged to consult relevant websites on the history and general design of clinical trials.
Indicative Topics
Students will study the following topics:
- Good Clinical Practice
- Regulatory authorities
- Protection of clinical research subjects
Version History
Title: LBIOL4276A Regulatory Environment in Clinical Trials Course Descriptor
Approved by: Academic Board Location: Academic Handbook/Programme specifications and Handbooks/ Undergraduate Apprenticeship Programmes/BSc (Hons) Applied Biomedical Sciences with Clinical Trials Programme Specification/Course Descriptors |
|||||
Version number | Date approved | Date published | Owner | Proposed next review date | Modification (As per AQF4) & category number |
1.0 | July 2024 | July 2024 | Dr Helen Dawe | July 2028 |